D-0663-2018 Class II Terminated
FDA drug recall D-0663-2018 was initiated by Partell Specialty Pharmacy on Mar 22, 2018 and is designated Class II. Reason for recall: Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization. The recall status is terminated (terminated Jan 15, 2019).
Recall Details
- Product Type
- Drugs
- Report Date
- Apr 25, 2018
- Initiation Date
- Mar 22, 2018
- Termination Date
- Jan 15, 2019
- Voluntary/Mandated
- Voluntary: Firm initiated
Product Description
Testosterone 100 mg pellet packaged in amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800
Reason for Recall
Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.
Distribution Pattern
NV only
Code Information
Lot#: 20171212@17, BUD 06/10/2018; 20180205@40, BUD 08/04/2018; 20180208@42, BUD 08/07/2018; 20170929@42, BUD 03/28/2018; 20171013@33, BUD 04/11/2018; 20171020@25, BUD 04/18/2018; 20171025@52, BUD 04/23/2018; 20171101@70, BUD 04/30/2018; 20171106@31, BUD 05/05/2018; 20171116@17, BUD: 05/15/2018, 20171116@42, BUD 05/15/2018; 20180117@87, BUD: 07/16/2018; 20180201@76, BUD 07/31/2018; 20180220@67, BUD 08/19/2018; 20180202@67, BUD 08/01/2018.
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-0663-2018
- openFDA file date
- Oct 26, 2026
- Loaded by RegDataLab
- Oct 27, 2026